Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1283, 2010-01, pp. : 8-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
IFN-α activates `silent' coeliac disease in predisposed patients
Reactions Weekly, Vol. 1, Iss. 1031, 2004-01 ,pp. :
Access to resources
Recommend
Evaluating EVR to PEG IFN-α-2b/ribavirin therapy worthwhile
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 491, 2005-01 ,pp. :
Sunitinib benefits HRQOL more than IFN-α in renal cell carcinoma
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 523, 2007-01 ,pp. :
REPEAT reaffirms the benefits of retreatment with PEG IFN-α-2a
Inpharma, Vol. 1, Iss. 1524, 2006-01 ,pp. :